Impact of biliary complications on quality of life in live-donor liver transplant recipients

Table 1 Descriptive categorical data for live-donor liver transplant recipients with biliary complications

Variable		n (%)
Indication of liver transplantation	HCV	21 (84)
	HBV	1 (4)
	Combined HCV and HBV	1 (4)
	Hepatocellular carcinoma	2 (8)
Donors’ gender	Male	17 (68)
	Female	8 (32)
Recipients’ gender	Male	19 (76)
	Female	6 (24)
Immunosuppressant	Tacrolimus	22 (88)
	Cyclosporine	3 (12)
Biliary leakage	-	7 (28)
	+	18 (72)
Need of pigtail catheter for biloma (total = 18)	-	15 (83.3)
	+	3 (16.6)
Biliary infection	-	0 (0)
	+	25 (100)
Frequency of biliary infection (total = 25)	1-2 Episodes	16 (64)
	≥ 3 Episodes	9 (36)
Biliary stricture	-	5 (20)
	+	20 (80)
Frequency of biliary stricture (total = 20)	1-2 Episodes	13 (65)
	≥ 3 Episodes	7 (28)
Need for ERCP	-	5 (20)
	+	20 (80)
Frequency of ERCP	1-2 ERCP	13 (65)
	≥ 3 ERCP	7 (28)
Need for PTC	-	22 (88)
	+	3 (12)
Frequency of PTC	1 PTC	2 (66.6)
	2 PTC	1 (33.3)
Surgical intervention for stricture	-	19 (95)
	+	1 (5)
Admission related to biliary complications	-	0 (0)
	+	25 (100)
Early biliary infection (total = 25)	-	2 (8)
	+	23 (92)
Early biliary stricture (total = 20)	-	17 (68)
	+	8 (32)

Data presented in number (n) and percentage (%). ERCP: Endoscopic retrograde cholangiopancreatography; HBV: Hepatitis B virus; HCV: Hepatitis C virus; PTC: Percutaneous transhepatic cholangiography.